The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease
Research output: Contribution to journal › Journal article › Research › peer-review
OBJECTIVE: The inflammatory biomarker YKL-40 is elevated and associated with mortality in patients with stable coronary artery disease (CAD). The aim was to investigate the influence of statin treatment and lipid status on serum YKL-40 and Hs-CRP in patients with stable CAD. DESIGN: Serum YKL-40, HsCRP, total cholesterol, HDL-c, LDL-c and triglycerides levels were measured in 404 statin treated and in 404 matched non-statin treated patients with stable CAD. RESULTS: YKL-40 was significantly higher in non-statin treated 110 µg/l (median) compared with 65 µg/l in statin treated (p
| Original language | English |
|---|---|
| Journal | Inflammation Research |
| Volume | 60 |
| Issue number | 3 |
| Pages (from-to) | 281-7 |
| Number of pages | 7 |
| ISSN | 1023-3830 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 32108354